GeneDx Holdings Corp. Class A Common Stock (WGS) Stock Price, Quote & AI Analysis
Live WGS stock price, real-time charts, AI-powered trade signals, technical analysis, earnings insights, and market sentiment for GeneDx Holdings Corp. Class A Common Stock.
TradeVae provides AI-driven analysis and real-time market intelligence for GeneDx Holdings Corp. Class A Common Stock (WGS), including price action, technical indicators, earnings performance, analyst sentiment, and short-term trade setups.
AI Analysis
Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.
Generating AI analysis...
GeneDx Holdings Corp. Class A Common Stock's fundamentals reflect its scale, profitability, and position within the global technology sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.
GeneDx Holdings Corp. Class A Common Stock Overview
Company information
Company Overview
GeneDx Holdings Corp. operates as a health intelligence company. It engages in healthcare with the use of its collected disease data sets. It offers exome and genome testing for diagnosis of genetic disease. The company was founded by Eric Schadt in October 2015 and is headquartered in Stamford, CT.
Company Details
Technical Indicators
Key technical analysis metrics and signals
Loading technical indicators...
Valuation Metrics
Key valuation ratios and comparisons
Loading valuation metrics...
GeneDx Holdings Corp. Class A Common Stock Earnings & Financial Statements
Earnings Calendar
Upcoming earnings dates and historical surprises
Loading earnings calendar...
Financial Statements
Income statements, balance sheets, and cash flow
Loading income statements...
Loading balance sheets...
Loading cash flow statements...